Date
The Issue: Due to unprecedented demand for propofol across Canada throughout the waves of the COVID-19 pandemic, Health Canada previously approved the importation of US-labelled propofol 10 mg/mL X 100 mL vials from Sagent Pharmaceuticals (Omega) as a national safety stock. Now that propofol demand has decreased, the provinces have been given a supply of these vials to use before they expire on December 31, 2022. Northern Health has received several months worth of stock of this product which will soon be available for use in relevant patient care areas.